Cart
sales@molnova.com
CZL55
CAS No. 667408-87-9
CZL55( —— )
Catalog No. M36542 CAS No. 667408-87-9
CZL55 is a potent caspase-1 inhibitor with an IC50 value of 0.024 μM.CZL55 has low cytotoxicity and can be used in the study of febrile seizures (FS).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 57 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 219 | In Stock |
|
| 100MG | 321 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCZL55
-
NoteResearch use only, not for human use.
-
Brief DescriptionCZL55 is a potent caspase-1 inhibitor with an IC50 value of 0.024 μM.CZL55 has low cytotoxicity and can be used in the study of febrile seizures (FS).
-
DescriptionCZL55 is a caspase-1 inhibitor with an IC50 value of 24 nM. CZL55 can be used for the research of febrile seizures (FS).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number667408-87-9
-
Formula Weight386.4
-
Molecular FormulaC20H22N2O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 166.67 mg/mL (431.34 mM; Ultrasonic )
-
SMILESN(C(=O)C1=CC(NC(CCCC(O)=O)=O)=CC=C1)C2=C(OC)C=C(OC)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tang Y, et al. Structure-based discovery of CZL80, a caspase-1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility. Br J Pharmacol. 2020 Aug;177(15):3519-3534.?
molnova catalog
related products
-
Ac-YVAD-AOM
Ac-YVAD-AOM is a selective and potent caspase-1 inhibitor showing antitumor activity and potential analgesic activity.
-
Estramustine phospha...
Estramustine phosphate sodium is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle.
-
Puerarin 6''-O-Xylos...
Puerarin 6''-O-xyloside possesses significant anti-osteoporotic activity on ovariectomy mice it has significant antitumour activities the mechanisms are related to increased levels of caspase-3 caspase-7 caspase-9 and Bax and reduced levels Bcl-2.
